Atavistik Bio, Pfizer collaborate to accelerate discovery of novel precision Allosteric Therapeutics
Cambridge: Atavistik Bio, a biotechnology company has announced that it has entered into a research collaboration with Pfizer ...
Pfizer (NYSE:PFE) has entered into a collaborative research agreement with Atavistik Bio for the discovery of novel precision ...
This partnership could redefine precision medicine with groundbreaking therapeutics targeting "impossible" proteins.
Atavistik Bio Inc. has entered into a research collaboration with Pfizer Inc. to accelerate the discovery of novel precision allosteric therapeutics for unmet medical needs. Under the collaboration, ...
Collaboration will leverage Atavistik Bio’s proprietary AMPS™ platform to rapidly identify and validate novel allosteric ...
Collaboration will leverage Atavistik Bio’s proprietary AMPS™ platform to rapidly identify and validate novel allosteric binders against two undisclosed, Pfizer-designated targets Atavistik ...
Atavistik Bio, Pfizer Collaborate To Accelerate Discovery Of Novel Precision Allosteric Therapeutics
(RTTNews) - Biotechnology company Atavistik Bio announced Thursday that it has entered into a research collaboration with Pfizer, Inc. (PFE) to accelerate the discovery of novel precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback